Search results for “Immunoglobulin Heavy Chain Variable Region” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 222 patents, we discovered top 45 key players by total patent application. Regeneron Pharmaceuticals, Inc., Avipep Pty Ltd., MedImmune LLC are dominant in this area. They take 52.70% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 88
Avipep Pty Ltd.
Australia
Patent: 16
MedImmune LLC
Louisiana, United States
Patent: 13
Merck Patent GmbH
Hessen, Germany
Patent: 9
Établissement Français du Sang
France
Patent: 8
Aveo Oncology Pharmaceuticals
Massachusetts, United States
Patent: 6
Immunomedics, Inc.
New Jersey, United States
Patent: 6
Merus NV
Utrecht, Netherlands
Patent: 5
AERES Biomedical Ltd.
United Kingdom
Patent: 5
Broteio Pharma BV
Zuid-Holland, Netherlands
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Scout Bio, Inc.
Pennsylvania, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 53 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Établissement Français du Sang, Université de Limoges take 79.25% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 31
Établissement Français du Sang
France
Patent: 8
Université de Limoges
France
Patent: 3
Centre National De La Recherche Scientif
France
Patent: 3
Merus NV
Utrecht, Netherlands
Patent: 2
Centre Hospitalier Universitaire de Limoges
France
Patent: 2
Broteio Pharma BV
Zuid-Holland, Netherlands
Patent: 2
Bristol Myers Squibb Co.
New York, United States
Patent: 1
Beijing Shijitan Hospital Affiliated to Capital Medical University
undefined undefined
Patent: 1
Aptevo Research And Development Llc
Washington, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 53 patents in last 5 years, we discover 10 new entrants. Établissement Français du Sang, Centre National De La Recherche Scientif, Université de Limoges are the most active new entrants in this area.
Établissement Français du Sang
France
Patent: 8
Centre National De La Recherche Scientif
France
Patent: 3
Université de Limoges
France
Patent: 3
Centre Hospitalier Universitaire de Limoges
France
Patent: 2
STARTUP
Scout Bio, Inc.
Pennsylvania, United States
Patent: 1
Bristol Myers Squibb Co.
New York, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Beijing Shijitan Hospital Affiliated to Capital Medical University
undefined undefined
Patent: 1
Harbour BioMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
Affiliated Hospital of Inner Mongolia University for Nationalities
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 6 universities and scientific research institutions by total patent application. Université de Limoges, Chiba University, Centre Hospitalier Universitaire de Limoges are dominant in this area. They take 42.11% of the total patent filing.
Université de Limoges
France
Patent: 3
Chiba University
Chiba-ken, Japan
Patent: 2
Centre Hospitalier Universitaire de Limoges
France
Patent: 2
Washington University in St. Louis
Missouri, United States
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
Fourth Military Medical University
Hunan Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: